It is becoming increasingly apparent that PKM2, the participant in the glucose reprogramming and drug resistance of tumor cells, may be the potential substrate of HSP90 (Taipale et al., 2010; Zuo et al., 2012; Asthana et al., 2013; Liu et al., 2016b). The gene discussed is PKM; the disease is neoplasm.